The coronavirus disease 2019 (COVID19) pandemic continues to represent a substantial
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …

Abstract Purpose of Review Due to the rapidly changing landscape of COVID-19, the
purpose of this review is to provide a concise and updated summary of pediatric COVID-19 …

The eligibility of COVID-19 vaccines has been expanded to children aged 12 and above in
several countries including Japan, and there is a plan to further lower the age. This study …

Objectives Multi-system inflammatory syndrome in children (MIS-C) is a less understood and
a rare complication of coronavirus disease-2019 (COVID-19). Given the scarce data …

Background With the emergence of the COVID-19 pandemic, increasing numbers of cases
of the multisystem inflammatory syndrome in children (MIS-C) have been reported …

Multisystem inflammatory syndrome in children (MIS-C) is a hyperinflammatory response
observed in children several weeks to months after acute infection with severe acute …

Abstract According to the World Health Organisation, as of October 2022, there have been
55,560,329 reported cases of SARS‐COV‐2 in patients under 19 years old. It is estimated …

In December 2019, the first case of coronavirus disease (COVID-19) was first reported in
Wuhan, China. As of March 2021, there were more than 120 million confirmed cases of …

Background Few single center studies from resource-poor settings have reported about the
epidemiology, clinical feature and outcome of multisystem inflammatory syndrome in …

Background: Describe the incidence and associated outcomes of gastrointestinal (GI)
manifestations of acute coronavirus disease 2019 (COVID-19) and multisystem inflammatory …